On Air Now

Listen

Listen Live Now » 101.9 FM Central Wisconsin

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
63° Feels Like: 63°
Wind: W 15 mph Past 24 hrs - Precip: 0.01”
Current Radar for Zip

Tonight

Scattered Thunderstorms 61°

Tomorrow

Isolated Thunderstorms 71°

Sun Night

Scattered Thunderstorms 52°

Alerts

Shire says new dry-eye drug fails to meet trial goal

LONDON (Reuters) - Drugmaker Shire said on Wednesday that its Lifitegrast treatment for adults with dry eye disease failed to meet one of two goals in a late-stage trial, the same result it saw in trial results in December. [ID:nL5N0JL1A5]

The drug met one goal for patient-reported symptoms of dry eye compared with placebo, the company said, but did not meet the second target based on signs of corneal staining.

Lifitegrast - a potential competitor for Allergan's Restasis, which is expected to have sales of around $900 million this year - is viewed as a key new product for Shire as it seeks to diversify its product line-up.

(Reporting by Paul Sandle; Editing by Brenda Goh)

Comments